MEBENDAZOLE TABLETS
Land: Irland
Språk: engelska
Källa: HPRA (Health Products Regulatory Authority)
Produktens egenskaper
(SPC)
10-05-2024
Vissa dokument för denna produkt är för närvarande inte tillgängliga, du kan skicka en begäran till vår kundservice och vi kommer att meddela dig så snart vi kan få dem.
Skicka förfrågan.
Skicka förfrågan.
Aktiva substanser:
MEBENDAZOLE
Tillgänglig från:
Cupal Limited
Dos:
100 Milligram
Tillstånd datum:
2003-09-05
Produktens egenskaper
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Mebendazole Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Mebendazole 100 mg.
_For excipients, see 6.1._
3 PHARMACEUTICAL FORM
Chewable tablet
Mottled, pale orange, round tablets, shallow, concave with a breakline.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
For the treatment of threadworm (enterobiasis) infestation.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Adults, the elderly and children over two years old:
One tablet to be chewed or swallowed whole. The efficacy in threadworm infestations is such that treatment failure
will be rare. However, the possibility of re-infection means that some patients may require a second tablet after two
weeks, if re-infected.
It is strongly recommended that all members of the family are treated at the same time.
Not recommended for children under two years of age.
4.3 CONTRAINDICATIONS
Pregnancy: Mebendazole has not been studied extensively in children under two years of age - for this reason it is not
currently recommended for children under two years of age.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
1.
Not to be taken during pregnancy, or whilst breast feeding.
2.
Not recommended for children under two years.
3.
Keep out of the reach and sight of children.
4.
If after two weeks you need to take a second tablet following which your symptoms persist, then consult your
doctor.
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION
None stated.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 12/04/2010_
_CRN 2080858_
_page number: 1_
4.6 PREGNANCY AND LACTATION
Mebendazole has shown embryotoxic and teratogenic activity in rats at single oral doses. N
Läs hela dokumentet
